FDA Inspection 1182373 — Greer Laboratories, Inc.

Greer Laboratories, Inc. — FEI 1011574

The FDA completed an inspection of Greer Laboratories, Inc. on Nov 1, 2022 in Lenoir, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 7 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 1, 2022
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Lenoir, NC (United States)

Citations

IDCFRDescription
1472021 CFR 820.50(a)(3)Acceptable supplier records, inadequate records
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
319121 CFR 820.30(g)Design validation - production units
366821 CFR 820.20(c)Management review dates
369621 CFR 820.100(b)Documentation
419321 CFR 806.10(b)Time to report - 10 days

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.